Skip to main navigation Skip to search Skip to main content

FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer

  • Paola Chiodelli
  • , Daniela Coltrini
  • , Marta Turati
  • , Marianna Cerasuolo
  • , Federica Maccarinelli
  • , Sara Rezzola
  • , Elisabetta Grillo
  • , Arianna Giacomini
  • , Sara Taranto
  • , Silvia Mussi
  • , Alessia Ligresti
  • , Marco Presta
  • , Roberto Ronca

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)217-224
Number of pages8
JournalCancer Letters
Volume526
DOIs
Publication statusPublished - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Castrate resistant prostate cancer
  • FGFR inhibitor
  • Mathematical model
  • Pemigatinib
  • Prostate cancer
  • TRAMP

Cite this